Two is better than one

The Lancet Infectious Diseases

Volumn 11, Issue 12, 2011, Pages 889-891

  Lu, Shan ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE;

ANTIBODY RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; LETTER; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEASONAL INFLUENZA;

HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, DNA;

EID: 81855194157     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70256-0     Document Type: Letter

References (7)

1. Ledgerwood JE, Wei C-J, Hu Z, the VRC 306 Study Team, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis 2011, published online Oct 4. 10.1016/S1473-3099(11)70240-7.
2. Lu S Heterologous prime-boost vaccination. Curr Opinn Immunol 2009, 21:346-351.
3. Wang S, Taaffe J, Parker C, Solorzano A, Garcia-Sastre A, Lu S Heterologous HA DNA vaccine prime-inactivated flu vaccineboost is more effective than using DNA or inactivated flu vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 2008, 26:3626-3633.
4. Suguitan AL, Cheng X, Wang W, Wang S, Jin H, Lu S Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. PLoS ONE 2011, 6:e21942.
5. Wei C-J, Boyington JC, McTamney PM, et al. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-1064.
6. Wang S, Kennedy JS, West K, et al. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 2008, 26:1098-1110.
7. Harari A, Bart PA, Stohr W, et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 2008, 205:63-77.